Targeting a new regulator of erythropoiesis to alleviate anemia.
Center for Molecular Immunology and Infectious Disease, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, Pennsylvania, USA.
Robert F
RF
Paulson
D030301:Activin Receptors, Type II / Q000378:metabolism*; D000740:Anemia / Q000097:blood / Q000188:drug therapy*; D000818:Animals; D019898:Autocrine Communication / Q000502:physiology; D019485:Bone Morphogenetic Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002454:Cell Differentiation; D004195:Disease Models, Animal; D004900:Erythroblasts / Q000378:metabolism*; D004920:Erythropoiesis / Q000187:drug effects*; D053222:Fas Ligand Protein; D005784:Gene Amplification / Q000502:physiology; D055412:Growth Differentiation Factors / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000882:Haplorhini; D006397:Hematinics / Q000494:pharmacology*; D008024:Ligands; D051379:Mice; D018384:Oxidative Stress / Q000502:physiology; D017382:Reactive Oxygen Species; D011993:Recombinant Fusion Proteins / Q000494:pharmacology*; D017086:beta-Thalassemia / Q000097:blood / Q000188:drug therapy; D019014:fas Receptor
D030301:Activin Receptors, Type II; D019485:Bone Morphogenetic Proteins; D053222:Fas Ligand Protein; D055412:Growth Differentiation Factors; D006397:Hematinics; D008024:Ligands; D017382:Reactive Oxygen Species; D011993:Recombinant Fusion Proteins; D019014:fas Receptor; C542017:sotatercept; C492266:GDF11 protein, human; C119153:Gdf11 protein, mouse; C425585:activin receptor type II-A